Abbott has succeeded where Biogen Idec failed last year in having a takeover offer accepted by Facet Biotech .
Abbott will pay $27 per share for Facet, which values the biotech at $722 million minus its cash and marketable securities of $272 ...
Sanofi-Aventis has exercised its option to combine its animal health business Merial with Intervet/Schering-Plough Animal Health , Merck & Co 's animal health unit.
Sanofi-Aventis bought out Merck's 50% share in Merial for $4 billion last July and ...
The US private equity firm, New Silk Route Partners (NSR), has invested Rs2.52 billion ($54.9 million) in Nectar Lifesciences of India.
Nectar informed the Bombay Stock Exchange that it had raised Rs910 million through an issue of 26 million shares ...
Astellas is continuing down the hostile path in its bid for OSI Pharmaceuticals , with the filing of a US lawsuit aimed at preventing its target from adopting any improper measures to thwart the planned acquisition.
The Japanese firm launched an ...
Astellas has launched a tender offer to acquire OSI Pharmaceuticals , despite the cancer, obesity and diabetes-focused company having previously turned down discussion requests.
Astellas will begin a tender offer on March 2nd to acquire all of ...
